Home » Authors » Christopher Delporte

Articles by Christopher Delporte

Emotional testimony presented on lifting breast implant ban

April 12, 2005

By Christopher Delporte

CMS funds back small-practice adoption of EHR technology

April 8, 2005

By Christopher Delporte

Summit highlights quality gaps, disparity in U.S. healthcare

April 7, 2005

By Christopher Delporte

Summit highlights quality gaps, disparity in U.S. healthcare

April 6, 2005

By Christopher Delporte

Life after DES: Looking for the next blockbuster product

April 4, 2005

By Christopher Delporte

Minimally invasive procedures are the name of the game

April 1, 2005

By Christopher Delporte

Wilson Greatbatch powers up for growth beyond batteries

March 31, 2005

By Christopher Delporte

CryoCath to begin new IDE study for AF ablation device

March 30, 2005

By Christopher Delporte

Washington Roundup: Medicare: Trustees report sees mixed bag for future solvency

March 29, 2005

By Christopher Delporte

FDA approves Gore's TAG as first device for treating TAA

March 25, 2005

By Christopher Delporte

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...